Literature DB >> 20042746

Responses to 2009 H1N1 vaccine in children 3 to 17 years of age.

Adriano Arguedas, Carolina Soley, Kelly Lindert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20042746     DOI： 10.1056/NEJMc0909988

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Authors:  Sharon E Frey; David I Bernstein; Michael A Gerber; Harry L Keyserling; Flor M Munoz; Patricia L Winokur; Christine B Turley; Richard E Rupp; Heather Hill; Mark Wolff; Diana L Noah; Allison C Ross; Gretchen Cress; Robert B Belshe
Journal:  J Infect Dis       Date:  2012-07-16       Impact factor: 5.226

2.  Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.

Authors:  Chiara Agrati; Cristiana Gioia; Concetta Castilletti; Daniele Lapa; Giulia Berno; Vincenzo Puro; Fabrizio Carletti; Eleonora Cimini; Carla Nisii; Flora Castellino; Federico Martini; Maria R Capobianchi
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-08       Impact factor: 2.205

3.  Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.

Authors:  Patricia M Flynn; Sharon Nachman; Petronella Muresan; Terence Fenton; Stephen A Spector; Coleen K Cunningham; Robert Pass; Ram Yogev; Sandra Burchett; Barbara Heckman; Anthony Bloom; L Jill Utech; Patricia Anthony; Elizabeth Petzold; Wende Levy; George K Siberry; Ruth Ebiasah; Judi Miller; Edward Handelsman; Adriana Weinberg
Journal:  J Infect Dis       Date:  2012-05-21       Impact factor: 5.226

4.  Clinical features of hospitalised children with 2009 H1N1 influenza virus infection.

Authors:  Carmelina Calitri; Clara Gabiano; Silvia Garazzino; Michele Pinon; Marisa Zoppo; Margherita Cuozzo; Carlo Scolfaro; Pier-Angelo Tovo
Journal:  Eur J Pediatr       Date:  2010-07-22       Impact factor: 3.183

5.  Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Authors:  Sharon E Frey; David I Bernstein; Rebecca C Brady; Wendy A Keitel; Hana El Sahly; Nadine Georges Rouphael; Mark J Mulligan; Robert L Atmar; Srilatha Edupuganti; Shital M Patel; Michelle Dickey; Irene Graham; Edwin L Anderson; Diana L Noah; Heather Hill; Mark Wolff; Robert B Belshe
Journal:  Vaccine       Date:  2014-11-11       Impact factor: 3.641

6.  Humoral and cell-mediated immune responses to monovalent 2009 influenza A/H1N1 and seasonal trivalent influenza vaccines in high-risk children.

Authors:  Caroline B Long; Irene Ramos; Deepa Rastogi; Deepa Manwani; Ginger Janow; Marcela Del Rio; Marguerite Mayers; Betsy C Herold; Ana Fernandez-Sesma; Rebecca Pellett Madan
Journal:  J Pediatr       Date:  2011-08-15       Impact factor: 4.406

7.  Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.

Authors:  Claire S Waddington; W T Walker; C Oeser; A Reiner; T John; S Wilkins; M Casey; P E Eccleston; R J Allen; I Okike; S Ladhani; E Sheasby; K Hoschler; N Andrews; P Waight; A C Collinson; P T Heath; A Finn; S N Faust; M D Snape; E Miller; A J Pollard
Journal:  BMJ       Date:  2010-05-27

8.  A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

Authors:  Otfried Kistner; Brian A Crowe; Walter Wodal; Astrid Kerschbaum; Helga Savidis-Dacho; Nicolas Sabarth; Falko G Falkner; Ines Mayerhofer; Wolfgang Mundt; Manfred Reiter; Leopold Grillberger; Christa Tauer; Michael Graninger; Alois Sachslehner; Michael Schwendinger; Peter Brühl; Thomas R Kreil; Hartmut J Ehrlich; P Noel Barrett
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

9.  Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth.

Authors:  Robert F Pass; Sharon Nachman; Patricia M Flynn; Petronella Muresan; Terence Fenton; Coleen K Cunningham; William Borkowsky; James B McAuley; Stephen A Spector; Elizabeth Petzold; Wende Levy; George K Siberry; Ed Handelsman; L Jill Utech; Adriana Weinberg
Journal:  J Pediatric Infect Dis Soc       Date:  2013-07-17       Impact factor: 3.164

10.  Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.

Authors:  Karen L Kotloff; Natasha B Halasa; Christopher J Harrison; Janet A Englund; Emmanuel B Walter; James C King; C Buddy Creech; Sara A Healy; Rowena J Dolor; Ina Stephens; Kathryn M Edwards; Diana L Noah; Heather Hill; Mark Wolff
Journal:  Pediatr Infect Dis J       Date:  2014-08       Impact factor: 2.129
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.